2016
DOI: 10.1038/celldisc.2015.46
|View full text |Cite
|
Sign up to set email alerts
|

Involvement of PARP1 in the regulation of alternative splicing

Abstract: Specialized chromatin structures such as nucleosomes with specific histone modifications decorate exons in eukaryotic genomes, suggesting a functional connection between chromatin organization and the regulation of pre-mRNA splicing. Through profiling the functional location of Poly (ADP) ribose polymerase, we observed that it is associated with the nucleosomes at exon/intron boundaries of specific genes, suggestive of a role for this enzyme in alternative splicing. Poly (ADP) ribose polymerase has previously … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
111
1

Year Published

2016
2016
2021
2021

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 64 publications
(125 citation statements)
references
References 86 publications
13
111
1
Order By: Relevance
“…As an example application, we utilised this methodology to elucidate the first direct and quantitative comparison between the intracellular response in ADP-ribosylation to two clinical PARP inhibitors, Olaparib and Rucaparib. Our findings are in agreement with the recent reports that indicate pivotal functional roles of PARylation in mRNA splicing and modulation of RNAs 25,26,27,28,29 . This finding is further supported by a recent CRISPR screen that identified several high-confidence mRNA splicing factors, including DDX46 and SRSF11 (lower left quadrant in Figure 4A) which resulted in increased sensitivity to the PARP inhibitor Olaparib across several cell lines when mutated 30 .…”
Section: Discussionsupporting
confidence: 94%
“…As an example application, we utilised this methodology to elucidate the first direct and quantitative comparison between the intracellular response in ADP-ribosylation to two clinical PARP inhibitors, Olaparib and Rucaparib. Our findings are in agreement with the recent reports that indicate pivotal functional roles of PARylation in mRNA splicing and modulation of RNAs 25,26,27,28,29 . This finding is further supported by a recent CRISPR screen that identified several high-confidence mRNA splicing factors, including DDX46 and SRSF11 (lower left quadrant in Figure 4A) which resulted in increased sensitivity to the PARP inhibitor Olaparib across several cell lines when mutated 30 .…”
Section: Discussionsupporting
confidence: 94%
“…PARP9 and PARP10 both modulate transcription and participate in the DNA damage response (103)(104)(105). A role for PARP1 in cotranscriptional gene splicing has been identified (33).…”
Section: Parps As Transcription Factor Coactivators/corepressorsmentioning
confidence: 99%
“…One possible mechanism by which iAs influences AS may be through an inhibition of DNA binding by alternative splicing regulators such as CCCTC-binding factor (CTCF) and poly (ADP) ribose polymerase (PARP1) (132,137,138). Interestingly, PARP1 co-localizes with CTCF on chromatin; this complex, with CTCF-dependent automodification of PARP1, permits PARylation activity in the absence of DNA damage (137,139).…”
Section: Alternative Splicingmentioning
confidence: 99%
“…Interestingly, PARP1 co-localizes with CTCF on chromatin; this complex, with CTCF-dependent automodification of PARP1, permits PARylation activity in the absence of DNA damage (137,139). Importantly, many splicing factors are regulated by PARylation (140)(141)(142)(143)(144) and any iAs-mediated inhibition of PARP1 binding to DNA not only affects the structural properties of chromatin but also the PARylation activities, which indirectly affect splicing decisions.…”
Section: Alternative Splicingmentioning
confidence: 99%